Back

Restricted mean survival time analysis to assess efficacy and safety of intensive vs standard blood pressure treatment goals as a function of age: insights from the SPRINT trial

3 September 2019 (12:40 - 13:30)
Organised by:
Congress Presentation Part of: Hypertension: epidemiology, targets and comorbidities Clinical ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Ashok Krishnaswami

Kaiser Permanente San Jose Medical Centre, San Jose (United States of America)

6 More presentations in this session

Presentation thumbnail
2018 ESC/ESH guideline-recommended age categories and intensive blood pressure management in high-risk adults: insights from SPRINT
Doctor M. Pareek (Copenhagen, DK)
Abstract Slides
Presentation thumbnail
All-cause mortality and cardiovascular death according to blood pressure thresholds recommended by ACC/AHA
Doctor G. Joseph (Roskilde, DK)
Abstract Slides
Presentation thumbnail
Association of systolic blood pressure and cardiovascular outcomes at different age groups in the healthy general population: a nationwide prospective cohort study
Doctor M. Jung (Seoul, KR)
Abstract Slides
Presentation thumbnail
Do hypertensive women with coronary artery disease benefit from lowering systolic blood pressure under 130 mmHg? Long-term mortality in the INternational VErapamil SR-trandolapril STudy (INVEST)
Doctor R. Sava (Tournai, BE)
Abstract Slides
Presentation thumbnail
Optimal blood pressure in diabetic hypertensive patients with overt proteinuria
Professor S. Park (Seoul, KR)
Abstract Slides

Access the full session

Session thumbnail
Hypertension: epidemiology, targets and comorbidities

The Event

Event poster

ESC Congress 2019

3 September 2019 12:40 CET
You may be interested in
thumbnail
Webinar
Management of blood pressure: selected case-based advice
thumbnail
Congress Session
Arterial hypertension
thumbnail
Congress Presentation
Highlights from the 2024 ESC Guidelines for the Management of Elevated Blood Pressure and Hypertension